Human Longevity
Human Longevity to Go Public Through $345M SPAC Merger
HLI and special purpose acquisition company Freedom Acquisition I claimed the transaction values the proposed combined company at approximately $1 billion.
Whole-Genome Sequencing, Deep Phenotyping Shows Many Adults Harbor Pathogenic Genetic Variants
The study, led by researchers from precision health firm Human Longevity, also uncovered phenotypic evidence supporting some pathogenic genetic findings.
NeoGenomics Acquires Human Longevity's Oncology Division for $37M
The oncology division of Human Longevity performs next-generation sequencing services for pharmaceutical customers and generated $10 million in revenue in 2019.
Human Longevity Raises $30M From Emerging Technology Partners, Healthcare Investors
The San Diego-based company plans to use the proceeds from the financing to enhance its Health Nucleus intelligence platform.
Apr 21, 2016